| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6280704 | VESSELON SPV LLC | Ultrasonic imaging system utilizing a long-persistence contrast agent |
Jul, 2013
(10 years ago) | |
| US6287539 | VESSELON SPV LLC | Methods of imaging using osmotically stabilized microbubble preparations |
Jul, 2013
(10 years ago) | |
| US6280705 | VESSELON SPV LLC | Kits & systems for ultrasonic imaging |
Jul, 2013
(10 years ago) | |
| US5605673 | VESSELON SPV LLC | Stabilized microbubble compositions for ultrasound |
Feb, 2014
(10 years ago) | |
| US5626833 | VESSELON SPV LLC | Ultrasound imaging method using microbubbles |
May, 2014
(9 years ago) | |
| US5639443 | VESSELON SPV LLC | Stabilized microbubble compositions |
Jun, 2014
(9 years ago) | |
| US5695741 | VESSELON SPV LLC | Stable microbubble precursors |
Dec, 2014
(9 years ago) | |
| US5720938 | VESSELON SPV LLC | Systems for the formation of microbubbles |
Feb, 2015
(9 years ago) | |
| US5798091 | VESSELON SPV LLC | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
Aug, 2015
(8 years ago) | |
Imagent is owned by Vesselon Spv Llc.
Imagent contains Dimyristoyl Lecithin; Perflexane.
Imagent has a total of 9 drug patents out of which 9 drug patents have expired.
Expired drug patents of Imagent are:
- US6280704
- US6287539
- US6280705
- US5605673
- US5626833
- US5639443
- US5695741
- US5720938
- US5798091
Imagent was authorised for market use on 31 May, 2002.
Imagent is available in injectable;intravenous dosage forms.
Imagent can be used as method of use of imagent.
The generics of Imagent are possible to be released after 25 August, 2015.
Drugs and Companies using DIMYRISTOYL LECITHIN; PERFLEXANE ingredient
Market Authorisation Date: 31 May, 2002
Treatment: Method of use of imagent
Dosage: INJECTABLE;INTRAVENOUS
IMAGENT family patents
